This article was originally published in The Tan Sheet
ProCaps Labs announces the launch of Cholox, promoting the product as a "safe and effective alternative to prescription statins." The company claims the product is "clinically proven to lower total and LDL cholesterol by 10-30% and reduce the risk of heart disease when combined with healthy diet and lifestyle." ProCaps notes Cholox' "unique active ingredient"- consisting of phytosterols - also is approved by FDA for its heart-healthy claims and backed by "dozens of clinical studies." The company offers a "30 points-in-30 days" money back guarantee. Capsules are sold in 90-, 180-, 360- and 1000-count packages...
You may also be interested in...
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’